Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results

Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results

Yuji Nozaki, Yasuaki Nagare, Chisato Ashida, Daisuke Tomita, Akinori Okada, Asuka Inoue, Koji Kinoshita, Masanori Funauchi, Itaru Matsumura Department of Hematology and Rheumatology, Kindai University School of Medicine, Osaka, Japan Purpose: We evaluated the clinical responses and radiographic outc...

Full description

Bibliographic Details
Main Authors: Nozaki Y, Nagare Y, Ashida C, Tomita D, Okada A, Inoue A, Kinoshita K, Funauchi M, Matsumura I
Format: Article
Language:English
Published: Dove Medical Press 2018-11-01
Series:Biologics : Targets & Therapy
Subjects:
rheumatoid arthritis
DAS28
infliximab
mTSS
dose adjustment
REVIVE
Online Access:https://www.dovepress.com/infliximab-dose-adjustment-can-improve-the-clinical-and-radiographic-o-peer-reviewed-article-BTT

Internet

https://www.dovepress.com/infliximab-dose-adjustment-can-improve-the-clinical-and-radiographic-o-peer-reviewed-article-BTT

Similar Items